True on getting to profits pretty quickly. The GenPrecis! offering seems to infer that their mfg capability in Korea is better than expected. The only question is how soon they can get it out.

The sales numbers were pretty modest and hopefully we'll see bigger increases by Q3.

Big second half for 2017 and 2018 seems to be shaping up pretty well.